Oric Pharmaceuticals, Inc. short interest in 2022
In 2022, Oric Pharmaceuticals, Inc.'s disclosed short interest ran from 6.30% of shares outstanding on 14 Jan 2022 to 8.94% on 30 Dec 2022, a change of +2.64 percentage points. The year's high was 12.37% on 13 May 2022 and its low 6.15% on 15 Dec 2022, averaging 7.78% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 49.07 days on 31 Oct 2022. Full history: Oric Pharmaceuticals, Inc..
Cite this page
By year: 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2022 in figures
- Start of year
- 6.30% (14 Jan 2022)
- End of year
- 8.94% (30 Dec 2022)
- Change
- +2.64 pp
- High
- 12.37% (13 May 2022)
- Low
- 6.15% (15 Dec 2022)
- Average
- 7.78%
- Highest days to cover
- 49.07 (31 Oct 2022)
- SEC filings marked
- 9
Every report in 2022
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 14 Jan 2022 | 6.30% | 14.17 | results (8-K) |
| 31 Jan 2022 | 7.17% | 12.21 | |
| 15 Feb 2022 | 8.06% | 16.10 | |
| 28 Feb 2022 | 8.89% | 15.78 | |
| 15 Mar 2022 | 8.50% | 11.45 | |
| 31 Mar 2022 | 6.47% | 1.59 | 10-K filed, results (8-K) |
| 14 Apr 2022 | 6.74% | 3.70 | |
| 29 Apr 2022 | 8.93% | 6.88 | |
| 13 May 2022 | 12.37% | 10.65 | 10-Q filed, results (8-K) |
| 31 May 2022 | 11.35% | 10.23 | |
| 15 Jun 2022 | 11.06% | 14.14 | |
| 30 Jun 2022 | 7.70% | 3.96 | |
| 15 Jul 2022 | 7.21% | 17.47 | |
| 29 Jul 2022 | 7.05% | 21.88 | |
| 15 Aug 2022 | 6.97% | 14.21 | 10-Q filed, results (8-K) |
| 31 Aug 2022 | 6.75% | 47.63 | |
| 15 Sep 2022 | 6.82% | 36.14 | |
| 30 Sep 2022 | 6.83% | 13.78 | |
| 14 Oct 2022 | 6.75% | 45.73 | |
| 31 Oct 2022 | 6.70% | 49.07 | |
| 15 Nov 2022 | 6.68% | 44.29 | 10-Q filed, results (8-K) |
| 30 Nov 2022 | 6.25% | 20.02 | |
| 15 Dec 2022 | 6.15% | 31.43 | |
| 30 Dec 2022 | 8.94% | 1.00 |
See also: Oric Pharmaceuticals, Inc.'s full history · most shorted US stocks of 2022 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.